EMERGENT BIOSOLUTIONS INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$1
Book Value Per Share
$9
Free Cash Flow Per Share
$3
Cash Per Share
$4
Revenue Per Share
$13
OCF Per Share
$3
Return on Equity
10.5%
Return on Assets
3.9%
Return on Invested Capital
5.5%
Debt to Equity
1.13
Current Ratio
5.01
Quick Ratio
2.41
Asset Turnover
0.55
Days Sales Outstanding
41.37
Days Payables Outstanding
62.21
Days Inventory On Hand
384.25
Cash Conversion Cycle
363.40
R&D / Revenue
7.2%
SBC / Revenue
2.2%
Capex / Revenue
1.9%
Working Capital
$530M
Net Current Asset Value
$-134M
Invested Capital
$1.11B
OCF / Net Income
3.24
FCF / Net Income
2.98
Accruals Ratio (Sloan)
-8.9%
Net Debt
$384M
Net Debt / EBITDA
1.96
Interest Coverage
1.69
Cash Coverage
2.88
Capex Coverage
12.36
Tangible Common Equity
$86M
TCE / Total Assets
6.5%
Goodwill / Total Assets
0.0%
NOPAT
$64M
Cash ROIC
13.7%
WC / Revenue
71.4%
Capex / D&A
0.14
Reinvestment Rate
-81.9%
Total Payout Ratio
47.3%
Asset Growth vs Revenue Growth
23.7%
Revenue 5Y CAGR
-13.7%
EPS 5Y CAGR
-29.6%
FCF 5Y CAGR
-16.9%
EBITDA 5Y CAGR
-16.5%
Book Value 5Y CAGR
-18.5%
Stock Price (FY-end)
$12
Market Cap
$701M
P/E Ratio
13.32
P/S Ratio
0.94
P/B Ratio
1.34
P/TB Ratio
8.14
P/OCF Ratio
4.11
P/FCF Ratio
4.47
Enterprise Value
$1.09B
EV / EBITDA
5.54
EV / Sales
1.46
EV / FCF
6.92
FCF Yield
22.4%
Shareholder Yield
1.2%
Buyback Yield
3.6%
R&D Yield
7.6%
Capex Yield
2.0%
Operating Leverage
1.22
Graham Number
$14
Shares Variation (YoY)
7.0%
Beta (5Y)
1.76
Cost of Equity
13.3%
Cost of Debt (after tax)
6.4%
WACC
10.1%
ROIC - WACC Spread
-4.6%
52W High
$13
52W Low
$4
Trailing Return 1Y
49.5%
Trailing Return 5Y
-87.0%
F-Score (Piotroski)
7.00
M-Score (Beneish)
-3.55
Z-Score (Altman)
1.66
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.